Page last updated: 2024-10-28

hydralazine and Carcinoma, Hepatocellular

hydralazine has been researched along with Carcinoma, Hepatocellular in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"This study investigates the use of hydralazine to enhance ultrasound hyperthermia for the treatment of hepatocellular carcinoma (HCC) by minimizing flow-mediated heat loss from the tumor."8.02Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma. ( Hunt, SJ; Karmacharya, MB; Sehgal, CM; Sultan, LR, 2021)
"This study investigates the use of hydralazine to enhance ultrasound hyperthermia for the treatment of hepatocellular carcinoma (HCC) by minimizing flow-mediated heat loss from the tumor."4.02Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma. ( Hunt, SJ; Karmacharya, MB; Sehgal, CM; Sultan, LR, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Sultan, LR2
Karmacharya, MB2
Al-Hasani, M1
Cary, TW1
Sehgal, CM2
Hunt, SJ1

Other Studies

2 other studies available for hydralazine and Carcinoma, Hepatocellular

ArticleYear
Hydralazine-augmented contrast ultrasound imaging improves the detection of hepatocellular carcinoma.
    Medical physics, 2023, Volume: 50, Issue:3

    Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Humans; Hydralazine; Liver Cirrhosis; Liver Neop

2023
Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma.
    Scientific reports, 2021, 07-30, Volume: 11, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Hydralazine; Hyperthermia, Ind

2021